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The population of individuals with arti-
ficial joints is steadily increasing, because
more devices are implanted, and the life
span of people with implants is longer.
During a 10-year period, the total number
of knee replacements increased from
270,000 to 550,000 per year, and the total
number of total hip replacements in-
creased from 120,000 to 200,000 per year
in the United States [1]. Prosthetic joint–
associated infection (PJI) is a devastating
complication that occurs in 0.3%–1% of
those patients who undergo total hip ar-
throplasty and in 1%–2% of patients after
total knee arthroplasty [2]. Of these epi-
sodes, 35%–40% occur by the hematog-
enous route [3]. Most of these episodes
are sequelae of Staphylococcus aureus sep-
sis, skin infection, or urosepsis [4–6].
It is conceivable that a small portion of
these PJI episodes are caused by transi-
tional bacteremia during dental work.
However, clinical experience does not fa-
vour this hypothesis, and to date, only few
indirect data were available for discussion.
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The potential origin of !10% of the mi-
croorganisms isolated from individuals
with PJI is oral or dental [7]. In a study
of 189 episodes of late infection that oc-
curred after total joint replacement, only
4 (2.1%) of the episodes were due to vir-
idans streptococci [8]. Moreover, a poten-
tial oral or dental origin is less likely to be
linked to a dental procedure than to poor
dental hygiene. Bartzokas et al [9] re-
ported 4 cases in which the infecting or-
ganism in the prosthesis was indistin-
guishable from isolates of the same species
obtained from the oral flora on cell wall
polypeptide electrophoresis. Examination
of the patients’ mouths revealed perio-
dontal disease and caries in all patients. In
contrast, and to the best of our knowledge,
the molecular proof of hematogenously
caused PJI as a direct sequel of previous
dental treatment is still lacking. Neverthe-
less, it cannot be excluded that a small
minority of hematogenous PJIs are caused
by bacteremia directly triggered by dental
manipulation. The rate of PJI attributable
to bacteremia after dental procedures has
been estimated from 0 of 112 cases [6] to
7 (0.2%) of 3490 cases [10].
This low number of cases can be also
explained by the bacterial density and the
duration of bacteremia during or after
dental manipulation. These 2 factors are
crucial for successful seeding on extravas-
cular devices [11]. In an experimental
model, the presence of a foreign body de-
creased the minimal abscess-forming dose
1100,000 fold [12]. This is attributable to
a locally acquired granulocyte defect [12].
Therefore, implants may be endangered
during episodes of bacteremia that are in-
duced by dental manipulation. However,
the density and duration of bacteremia is
much lower during dental work than it is
during overt sepsis. After dental extraction
in children, it ranges from 1 through 28
colony-forming units (CFU) per milliliter
of blood and does not exceed 15 min [13,
14]. In a guinea pig model, the critical
bacterial density in the bloodstream re-
sulting in permanent infection associated
with extravascular foreign bodies was at
least 100 CFU S. aureus per mL blood [11].
Similarly, in a rabbit prosthetic knee joint
model, 3 intravascular injections of high
doses (1109 CFU) of S. aureus were re-
quired to cause PJI [15]. This indicates
that hematogenous PJI does not generally
occur during transient low-inoculum bac-
teremia but, rather, occurs during clini-
cally overt sepsis.
In view of the devastating consequences
of PJI, many experts have published their
opinion regarding the possible benefit of
antibiotic prophylaxis before dental work
in patients with joint replacements. None
of these publications was based on an ap-
propriate clinical trial. Therefore, it does
not astonish that some of the experts ar-
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gued in favor of and others against pro-
phylaxis [16, 17]. In this confusing situ-
ation, the American Academy of Ortho-
pedic Surgeons (AAOS) and the American
Dental Association published a statement
reflecting the panel opinion on this topic
[18]. Interestingly, the original statement
of an expert panel of dentists, orthopedic
surgeons, and infectious disease specialists
concluded that “antibiotic prophylaxis is
not indicated for most dental patients with
total joint replacements” [18]. In the
meantime, a new statement by the AAOS
informs: “ … the AAOS recommends that
clinicians consider antibiotic prophylaxis
for all total joint replacement patients
prior to any invasive procedure that may
cause bacteremia” [19]. This discrepancy
is hard to understand. Because physicians
and dentists will follow the most recently
published AAOS information statement,
this has several unfavorable consequences:
First, general prophylaxis increases the
(unjustified) use of antibiotics; second, the
risk of adverse effects (eg, toxicity and al-
lergy) may not be counterbalanced by pre-
vention of PJI; and third, the dentist may
be sued for not giving antibiotics accord-
ing to the published consensus statement.
This unjustified liability problem can only
be tackled with conclusive data from a
clinical study.
In this issue of Clinical Infectious Dis-
eases, Berbari et al [20] present a case-
control study to examine the association
between dental procedures—with or with-
out antibiotic prophylaxis—and PJI. The
rationale for this study was the discrep-
ancy between the multitude of expert
opinions and the lack of evidence regard-
ing the benefit of antibiotic prophylaxis
before dental procedures. The authors
found no increased risk of PJI after dental
procedures. In addition, antibiotic pro-
phylaxis was not associated with risk
reduction.
Infectious diseases specialists envy the
sample sizes in clinical studies performed
by investigators who have access to very
large numbers of patients (eg, cardiology
studies), in which small differences in out-
comes can be thoroughly tested for their
statistical significance. However, PJI is a
rare event that occurs in ∼1% of all pri-
mary arthroplasties. The estimated pro-
portion of these cases attributed to dental
procedures is small (∼10%, or ∼0.1% of
all primary arthroplasties) [6, 10]. There-
fore, even when antibiotic prophylaxis
could prevent 80% of all potential he-
matogenous PJIs after dental procedure,
the absolute risk reduction would be only
∼0.08%. These figures indicate that at least
1250 individuals must be treated with pro-
phylactic antibiotics during dental pro-
cedures to prevent a single PJI. In other
words, proof of superiority of antibiotic
prophylaxis with a power of 80% in a pla-
cebo-controlled trial would require several
hundred thousands persons with joint re-
placements to undergo dental work, with
a follow-up of at least 2 years. Therefore,
a case-control study, as performed by Ber-
bari et al [20], is the only feasible option.
As with every case-control study, there
is an increased susceptibility to sampling
and differential measurement bias. Berbari
et al [20] elegantly minimized these po-
tential biases by sampling the case patients
and control subjects in the same way, by
using data (ie, dental charts) recorded be-
fore the outcome (PJI) occurred, and by
blinding the reviewer of the dental records
to the case or control status of the patient.
However, matching was not performed on
any variable. Yet, given the prospective
surveillance of this study and the high
number of variables reported to be asso-
ciated with an increased risk for PJI, it is
impossible to find a sufficient number of
control subjects with the same value of
potential confounding variables. Taken to-
gether, the study performed by Berbari et
al [20] is methodologically well conducted
and provides data on the topic of anti-
biotics for prevention of PJI during dental
procedures.
In 35 of the 339 episodes, PJI was po-
tentially caused by a microorganism from
the oral or dental flora. This number is
difficult to interpret, because the body site
of the bacteria’s origin was not examined,
and the PJI population includes both he-
matogenously and intraoperatively ac-
quired infections. However, antibiotic
prophylaxis could not lower the risk of PJI.
Although it is conceivable that hematog-
enous seeding from the oral flora to the
prosthetic joint does occur, these events
seem not to be directly associated with
dental procedures.
Good dental hygiene may, therefore, be
much more relevant than antibiotic pro-
phylaxis before dental manipulation. Ber-
bari et al [20] showed that more control
subjects than patients with PJI had mul-
tiple dental hygiene visits [63% vs 54%]
and that there was a trend for a lower risk
for developing a PJI if a patient had at
least 1 dental hygiene visit (odds ratio, 0.7;
95% confidence interval, 0.5–1.03; Pp
). This observation is important, be-.07
cause the fear of bacteremia may prevent
people with joint replacement from con-
sulting the dentist or undergoing dental
hygiene.
In conclusion, the study by Berbari et
al [20] has the potential to reassure the
responsible physicians and dentists that
antibiotic prophylaxis is not needed for all
patients with total joint replacement prior
to any dental procedure and to convince
individuals with joint replacement that
meticulous dental hygiene is important.
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